“Evaluation of UHRF1 and P16INK4A Expression Levels in Newly Diagnosed AML Patients”. Biomedical Research and Therapy, vol. 5, no. 9, Sept. 2018, pp. 2658-63, https://doi.org/10.15419/bmrat.v5i9.475.